MicroRNA 7 Impairs Insulin Signaling and Regulates Aβ Levels through Posttranscriptional Regulation of the Insulin Receptor Substrate 2, Insulin Receptor, Insulin-Degrading Enzyme, and Liver X Receptor Pathway

REFERENCES

• Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. 2006. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74. https://doi.org/10.1016/S1474-4422(05)70284-2.
   PubMed Web of Science ®Google Scholar
• Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE. 2012. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316–1338. https://doi.org/10.1172/JCI59903.
   PubMed Web of Science ®Google Scholar
• Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B. 2012. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69:29–38. https://doi.org/10.1001/archneurol.2011.233.
   PubMed Web of Science ®Google Scholar
• Ambros V. 2004. The functions of animal microRNAs. Nature 431:350–355. https://doi.org/10.1038/nature02871.
   PubMed Web of Science ®Google Scholar
• Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215–233. https://doi.org/10.1016/j.cell.2009.01.002.
   PubMed Web of Science ®Google Scholar
• Price NL, Ramirez CM, Fernandez-Hernando C. 2014. Relevance of microRNA in metabolic diseases. Crit Rev Clin Lab Sci 51:305–320. https://doi.org/10.3109/10408363.2014.937522.
   PubMed Web of Science ®Google Scholar
• Ramirez CM, Dávalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D, Suárez Y, Fernández-Hernando C. 2011. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 31:2707–2714. https://doi.org/10.1161/ATVBAHA.111.232066.
   PubMed Web of Science ®Google Scholar
• Ramírez CM, Goedeke L, Rotllan N, Yoon J-H, Cirera-Salinas D, Mattison JA, Suárez Y, de Cabo R, Gorospe M, Fernández-Hernando C. 2013. MicroRNA 33 regulates glucose metabolism. Mol Cell Biol 33:2891–2902. https://doi.org/10.1128/MCB.00016-13.
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernandez-Hernando C. 2010. miR-33 contributes to the regulation of cholesterol homeostasis. Science 328:1570–1573. https://doi.org/10.1126/science.1189862.
   PubMed Web of Science ®Google Scholar
• Bedse G, Di Domenico F, Serviddio G, Cassano T. 2015. Aberrant insulin signaling in Alzheimer’s disease: current knowledge. Front Neurosci 9:204. https://doi.org/10.3389/fnins.2015.00204.
   PubMed Web of Science ®Google Scholar
• Kim J, Yoon H, Ramirez CM, Lee SM, Hoe HS, Fernandez-Hernando C, Kim J. 2012. miR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp Neurol 235:476–483. https://doi.org/10.1016/j.expneurol.2011.11.010.
   PubMed Web of Science ®Google Scholar
• Latreille M, Hausser J, Stutzer I, Zhang Q, Hastoy B, Gargani S, Kerr-Conte J, Pattou F, Zavolan M, Esguerra JL, Eliasson L, Rulicke T, Rorsman P, Stoffel M. 2014. MicroRNA-7a regulates pancreatic beta cell function. J Clin Invest 124:2722–2735. https://doi.org/10.1172/JCI73066.
   PubMed Web of Science ®Google Scholar
• López-Beas J, Capilla-González V, Aguilera Y, Mellado N, Lachaud CC, Martín F, Smani T, Soria B, Hmadcha A. 2018. miR-7 modulates hESC differentiation into insulin-producing beta-like cells and contributes to cell maturation. Mol Ther Nucleic Acids 12:463–477. https://doi.org/10.1016/j.omtn.2018.06.002.
   PubMedGoogle Scholar
• Choudhury NR, de Lima Alves F, de Andrés-Aguayo L, Graf T, Cáceres JF, Rappsilber J, Michlewski G. 2013. Tissue-specific control of brain-enriched miR-7 biogenesis. Genes Dev 27:24–38. https://doi.org/10.1101/gad.199190.112.
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N. 2013. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495:333–338. https://doi.org/10.1038/nature11928.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Abdo S, Zhao S, Wu C-H, Shi Y, Lo C-S, Chenier I, Alquier T, Filep JG, Ingelfinger JR, Zhang S-L, Chan JSD. 2017. Insulin inhibits Nrf2 gene expression via heterogeneous nuclear ribonucleoprotein F/K in diabetic mice. Endocrinology 158:903–919. https://doi.org/10.1210/en.2016-1576.
   PubMed Web of Science ®Google Scholar
• Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. The human genome browser at UCSC. Genome Res 12:996–1006. https://doi.org/10.1101/gr.229102.
   PubMed Web of Science ®Google Scholar
• Singaravelu R, Quan C, Powdrill MH, Shaw TA, Srinivasan P, Lyn RK, Alonzi RC, Jones DM, Filip R, Russell RS, Pezacki JP. 2018. MicroRNA-7 mediates cross-talk between metabolic signaling pathways in the liver. Sci Rep 8:361. https://doi.org/10.1038/s41598-017-18529-x.
   PubMed Web of Science ®Google Scholar
• Janson J, Laedtke T, Parisi JE, O’Brien P, Petersen RC, Butler PC. 2004. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53:474–481. https://doi.org/10.2337/diabetes.53.2.474.
   PubMed Web of Science ®Google Scholar
• Sims-Robinson C, Kim B, Rosko A, Feldman EL. 2010. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 6:551–559. https://doi.org/10.1038/nrneurol.2010.130.
   PubMed Web of Science ®Google Scholar
• de la Monte SM. 2014. Type 3 diabetes is sporadic Alzheimers disease: mini-review. Eur Neuropsychopharmacol 24:1954–1960. https://doi.org/10.1016/j.euroneuro.2014.06.008.
   PubMed Web of Science ®Google Scholar
• Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM. 2005. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease—is this type 3 diabetes? J Alzheimers Dis 7:63–80. https://doi.org/10.3233/JAD-2005-7107.
   PubMed Web of Science ®Google Scholar
• Fernández-Hernando C, Ramírez CM, Goedeke L, Suárez Y. 2013. MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 33:178–185. https://doi.org/10.1161/ATVBAHA.112.300144.
   PubMed Web of Science ®Google Scholar
• Fineberg SK, Kosik KS, Davidson BL. 2009. MicroRNAs potentiate neural development. Neuron 64:303–309. https://doi.org/10.1016/j.neuron.2009.10.020.
   PubMed Web of Science ®Google Scholar
• Devi L, Alldred MJ, Ginsberg SD, Ohno M. 2012. Mechanisms underlying insulin deficiency-induced acceleration of beta-amyloidosis in a mouse model of Alzheimer’s disease. PLoS One 7:e32792. https://doi.org/10.1371/journal.pone.0032792.
   Google Scholar
• Burns MP, Vardanian L, Pajoohesh-Ganji A, Wang L, Cooper M, Harris DC, Duff K, Rebeck GW. 2006. The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo. J Neurochem 98:792–800. https://doi.org/10.1111/j.1471-4159.2006.03925.x.
   PubMed Web of Science ®Google Scholar
• Riddell DR, Zhou H, Comery TA, Kouranova E, Lo CF, Warwick HK, Ring RH, Kirksey Y, Aschmies S, Xu J, Kubek K, Hirst WD, Gonzales C, Chen Y, Murphy E, Leonard S, Vasylyev D, Oganesian A, Martone RL, Pangalos MN, Reinhart PH, Jacobsen JS. 2007. The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer’s disease. Mol Cell Neurosci 34:621–628. https://doi.org/10.1016/j.mcn.2007.01.011.
   PubMed Web of Science ®Google Scholar
• Vanmierlo T, Rutten K, Dederen J, Bloks VW, van Vark-van der Zee LC, Kuipers F, Kiliaan A, Blokland A, Sijbrands EJG, Steinbusch H, Prickaerts J, Lütjohann D, Mulder M. 2011. Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol Aging 32:1262–1272. https://doi.org/10.1016/j.neurobiolaging.2009.07.005.
   PubMed Web of Science ®Google Scholar
• Zelcer N, Tontonoz P. 2006. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116:607–614. https://doi.org/10.1172/JCI27883.
   PubMed Web of Science ®Google Scholar
• Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, Jain S, Hirsch-Reinshagen V, Wellington CL, Bales KR, Paul SM, Holtzman DM. 2008. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest 118:671–682. https://doi.org/10.1172/JCI33622.
   PubMed Web of Science ®Google Scholar
• Kim J, Yoon H, Horie T, Burchett JM, Restivo JL, Rotllan N, Ramirez CM, Verghese PB, Ihara M, Hoe HS, Esau C, Fernandez-Hernando C, Holtzman DM, Cirrito JR, Ono K, Kim J. 2015. MicroRNA-33 regulates ApoE lipidation and amyloid-beta metabolism in the brain. J Neurosci 35:14717–14726. https://doi.org/10.1523/JNEUROSCI.2053-15.2015.
   PubMed Web of Science ®Google Scholar
• Ray K. 2010. IDE and late-onset AD. Nat Rev Neurol 6:185. https://doi.org/10.1038/nrneurol.2010.24.
   Google Scholar
• Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, Frosch MP, Selkoe DJ. 2003. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40:1087–1093. https://doi.org/10.1016/s0896-6273(03)00787-6.
   PubMed Web of Science ®Google Scholar
• Sajan M, Hansen B, Ivey R, III, Sajan J, Ari C, Song S, Braun U, Leitges M, Farese-Higgs M, Farese RV. 2016. Brain insulin signaling is increased in insulin-resistant states and decreases in FOXOs and PGC-1alpha and increases in Abeta1-40/42 and phospho-Tau may abet Alzheimer development. Diabetes 65:1892–1903. https://doi.org/10.2337/db15-1428.
   PubMed Web of Science ®Google Scholar
• Chamorro-Jorganes A, Araldi E, Rotllan N, Cirera-Salinas D, Suárez Y. 2014. Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells. J Cell Sci 127:1169–1178. https://doi.org/10.1242/jcs.130518.
   PubMed Web of Science ®Google Scholar
• van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. 2007. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:575–579. https://doi.org/10.1126/science.1139089.
   PubMed Web of Science ®Google Scholar
• Nikolic I, Plate KH, Schmidt MHH. 2010. EGFL7 meets miRNA-126: an angiogenesis alliance. J Angiogenesis Res 2:9. https://doi.org/10.1186/2040-2384-2-9.
   PubMedGoogle Scholar
• Megraw M, Cumbie JS, Ivanchenko MG, Filichkin SA. 2016. Small genetic circuits and microRNAs: big players in polymerase II transcriptional control in plants. Plant Cell 28:286–303. https://doi.org/10.1105/tpc.15.00852.
   PubMed Web of Science ®Google Scholar
• Kim J, Yoon H, Chung DE, Brown JL, Belmonte KC, Kim J. 2016. miR-186 is decreased in aged brain and suppresses BACE1 expression. J Neurochem 137:436–445. https://doi.org/10.1111/jnc.13507.
   PubMed Web of Science ®Google Scholar